Work

Targeted Alpha Therapy of mCRPC with 225Actinium-PSMA617: Dosimetry, toxicity and duration of tumor-control.

Year: 2018

Type: article

Study design: Clinical Trial

Source: Joint Research Centre (European Commission)

Authors: Frank Bruchertseifer, Alfred Morgenstern, Frederik L. Giesel, Christos Apostolidis, Uwe Haberkorn, Clemens Kratochwil

Institution: Heidelberg University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2883583830

FWCI: 0.153

Cites:

Cited by: 1

Related to: 10